Algeta ASA, a Norwegian company focused on developing cancer therapeutics, has stepped up its business development strategy with the appointment of Donald Coppen. Dr. Coppen will take on the role of business development director and will work alongside CBO Roger Harrison. Dr. Coppen joins Algeta from British oncology company Biocompatibles International (now part of BTG Plc), where he was a director of partnering and licensing.
Copyright 2011 Evernow Publishing Ltd